ReviewJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2018
Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum.
Review in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
112 citing papers in PubMed, 5 syntheses or guidelines pooled it, 173 citations in OpenAlex.
- Racial inequalities in eligibility and access to lung cancer screening: systematic review of United States studies.BMC public health · 2025Pooled it
- Interventions to Reduce Lung Cancer and COPD-Related Stigma: A Systematic Review.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2024Pooled it
- Participant factors associated with psychosocial impacts of lung cancer screening: A systematic review.Cancer medicine · 2024Pooled it
- MALAT-1 Expression Correlates with Prognosis in Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis.Disease markers · 2021Pooled it
- Patient Adherence to Screening for Lung Cancer in the US: A Systematic Review and Meta-analysis.JAMA network open · 2020Pooled it
- Trial
- Bringing lung cancer above ground through storytelling: Creating a lung cancer advocacy network.PEC innovation · 2026Article
- Patients' and Providers' Perspective of a Multi-level Approach to Improve Participation in Low-dose CT for Lung Cancer Screening (Empower LCS): A Mixed-Methods Analysis.Academic radiology · 2026Article
- Perceived stigma among lung cancer patients: a cross-sectional study with latent profile analysis.BMC cancer · 2026Article
- A visual analysis of the research dynamics of biomarkers for lung cancer screening.Clinical epigenetics · 2026Article
- Reducing Stigma in Lung Cancer Screening: Co-Design of a Targeted Resource for Health Professionals in Australia.Health expectations : an international journal of public participation in health care and health policy · 2026Article
- Mindful self-compassion to reduce stigma among individuals diagnosed with lung cancer (MSC-LC): a pilot study protocol for a parallel-group, randomized controlled trial.Pilot and feasibility studies · 2026Article
- Article
- Confronting nihilism and stigma in lung cancer: The nurse practitioner's role in restoring hope and trust.Journal of the American Association of Nurse Practitioners · 2026Article
- Implementation of a hybrid lung health program for Northeast Texas: study protocol.Implementation science communications · 2026Article
- Development of a Web-Based Experiential Learning Intervention for the Public to Reduce Cancer Stigma: Tutorial on the Application of Intervention Mapping.JMIR cancer · 2026Article
- Health Beliefs and Adherence to Lung Cancer Screening in a Diverse Safety-Net Population.Journal of the National Comprehensive Cancer Network : JNCCN · 2026Article
- "I Am Not the One That Caused Your Illness": Lung Cancer Stigma in Nigeria.Psycho-oncology · 2026Article
- Editorial: Advancing diagnostic excellence in early lung cancer detection.Frontiers in oncology · 2026Article
- Exploring the expression and prognostic roles of LAD1 in lung adenocarcinoma.Scientific reports · 2025Article
52 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
Abstract
The public health imperative to reduce the burden of lung cancer has seen unprecedented progress in recent years. Fully realizing the advances in lung cancer treatment and control requires attention to potential barriers in their momentum and implementation. In this analysis, we present and evaluate the argument that stigma is a highly significant barrier to fulfilling the clinical promise of advanced care and reduced lung cancer burden. This evaluation of the stigma of lung cancer is based on a multilevel perspective that incorporates the individual, persons in the individual's immediate environment, the health care system, and the larger societal structure that shapes perceptions and decisions. We also consider current interventions and interventional needs within and across aspects of the lung cancer continuum, including prevention, screening, diagnosis, treatment, and survivorship. Current evidence suggests that stigma detrimentally affects psychosocial, communication, and behavioral outcomes over the entire lung cancer control continuum and across multiple levels. Interventional efforts to alleviate stigma in the context of lung cancer show promise, yet more work is needed to evaluate their impact. Understanding and addressing the multilevel role of stigma is a crucial area for future study to realize the full benefits offered by lung cancer prevention, control, and treatment. Coordinated, interdisciplinary, and well-conceptualized efforts have the potential to reduce the barrier of stigma in the context of lung cancer and facilitate demonstrable improvements in clinical care and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.